Premium
S5‐01‐01: AGEING AND NEUROIMMUNOLOGY: WHITE MATTER PATHOLOGY
Author(s) -
Simpson Julie E.,
Wharton Stephen,
Brayne Carol,
Matthews Fiona,
Heath Paul,
Ince Paul
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2964
Subject(s) - white matter , hyperintensity , dementia , neuropathology , pathology , neurodegeneration , medicine , vascular dementia , neuroscience , pathogenesis , lesion , disease , magnetic resonance imaging , biology , radiology
not available. S5-01-04 OLIGODENDROCYTES IN DEMENTIA Ragnhildur Thora Karadottir, University of Cambridge, Cambridge, United Kingdom. Contact e-mail: rk385@cam.ac.uk Abstract not available.not available. FEATURED RESEARCH SESSIONS F5-01 DOWN SYNDROME: IMAGING AND FLUID BIOMARKERS FROM THE ABC-DS CONSORTIUM F5-01-01 PROTEOMIC BIOMARKERS FOR DETECTING AND PREDICTING AD RISK AMONG ADULTS WITH DOWN SYNDROME Sid O’Bryant, Fan Zhang, Joseph H. Lee, Sharon J. Krinsky-McHale, Deborah Pang, Warren B. Zigman, Wayne Silverman, Nicole Schupf, University of North Texas Health Science Center, Fort Worth, TX, USA; University of Vermont, Burlington, VT, USA; Columbia University Medical Center, New York, NY, USA; New York State Institute for Basic Research, Staten Island, NY, USA; New York State Institute for Basic Research, Staten Island, NY, USA; New York State Institute for Basic Research, Staten Island, NY, USA; Kennedy Krieger Institute and Johns Hopkins University, Baltimore, MD, USA; Columbia University Irving Medical Center, New York, NY, USA. Contact e-mail: sid.obryant@unthsc.edu Background:Adults with Down syndrome (DS) are at substantially increased risk for developing Alzheimer’s disease (AD). Despite